Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 10, 2021

Total Value ($000): $459,637 (100.0% shares, 0.0% debt)

Holdings (6)

CNTA CENTESSA PHARMACEUTICALS PLC 65.1%

Value ($000) $299,329 Shares 17,923,892 Est. Cost $22.21 Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 14.4%

Value ($000) $66,378 Shares 2,067,861 Est. Cost $25.13 Unrealized +32.2%

PCVX VAXCYTE INC 10.4%

Value ($000) $47,885 Shares 1,887,478 Est. Cost $32.16 Unrealized -24.6%

— MERUS N V 7.7%

Value ($000) $35,200 Shares 1,600,000 Est. Cost $14.08 Unrealized —

— CHECKMATE PHARMACEUTICALS IN 1.3%

Value ($000) $5,962 Shares 1,501,716 Est. Cost $11.51 Unrealized —

— OBSEVA SA 1.1%

Value ($000) $4,883 Shares 1,570,000 Est. Cost $3.82 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	17,923,892	$299,329	65.1%	$22.21	—	SPONSORED ADS	152309100
PHAT	PHATHOM PHARMACEUTICALS INC	2,067,861	$66,378	14.4%	$25.13	+32.2%	COM	71722W107
PCVX	VAXCYTE INC	1,887,478	$47,885	10.4%	$32.16	-24.6%	COM	92243G108
—	MERUS N V	1,600,000	$35,200	7.7%	$14.08	—	COM	N5749R100
—	CHECKMATE PHARMACEUTICALS IN	1,501,716	$5,962	1.3%	$11.51	—	COM	162818108
—	OBSEVA SA	1,570,000	$4,883	1.1%	$3.82	—	COM	H5861P103